Anna U Severin, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1000 Se Uglow Ave, Dallas, OR 97338 Phone: 503-623-8376 Fax: 503-623-5293 |
Jacob Mitchell, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Se Uglow Ave, Dallas, OR 97338 Phone: 503-623-8376 |
Kari Wattenbarger, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 1000 Se Uglow Ave, Dallas, OR 97338 Phone: 503-623-8376 |
Chelsea Ruhoff Lee, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1000 Se Uglow Ave, Dallas, OR 97338 Phone: 503-623-8376 |
Mrs. Julia Lee Charmayne Pulliam, PA Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 641 Se Miller Ave, Dallas, OR 97338 Phone: 503-623-2345 Fax: 503-623-1944 |
News Archive
The immune system plays an important role in the heart's response to injury. But until recently, confusing data made it difficult to distinguish the immune factors that encourage the heart to heal following a heart attack, for example, from those that lead to further damage.
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a second preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.
Researchers at the University of South Australia are seeking volunteers for a new study into the potential health benefits of combining regular exercise with daily chocolate consumption.
Researchers have made rapid advances in understanding how to manipulate the immune system safely to destroy cancer cells. Adoptive transfer of haploidentical natural killer cells has shown promise as a treatment option to target and kill cancer cells in a less toxic way than conventional therapies. Now for the first time, scientists will combine NK cell therapy with an immunocytokine to target children with relapsed/refractory disease including those with bulky tumors.
› Verified 7 days ago